Acurx Pharmaceuticals
ACXP
ACXP
24 hedge funds and large institutions have $1.36M invested in Acurx Pharmaceuticals in 2025 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 6 increasing their positions, 5 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
less funds holding
Funds holding: →
29% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 7
Holders
24
Holding in Top 10
1
Calls
$5K
Puts
–
Top Buyers
| 1 | +$797K | |
| 2 | +$26.3K | |
| 3 | +$14.6K | |
| 4 |
NS
NBC Securities
Birmingham,
Alabama
|
+$11K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$9.74K |
Top Sellers
| 1 | -$39.4K | |
| 2 | -$23K | |
| 3 | -$17.3K | |
| 4 |
TWC
TD Waterhouse Canada
Toronto,
Ontario, Canada
|
-$14.9K |
| 5 |
Squarepoint
New York
|
-$10.2K |
